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Abstract 
One of the events occurring when a biomaterial is implanted in an host is the protein 
deposition onto its surface, which might regulate cell responses. When a biomaterial 
displays a compromised biocompatibility, distinct complement pathways can be 
activated to produce a foreign body reaction. In this article, we have designed different 
types of biomaterial surfaces to study the inflammation process. Here, we used different 
concentrations of (3-glycidoxypropyl)-trimethoxysilane (GPTMS), an organically-
modified alkoxysilane as a precursor for the synthesis of various types of sol-gel 
materials functionalizing coatings for titanium implants to regulate biological responses. 
Our results showed that increasing GPTMS concentration slightly enhanced the 
osteogenic potential of MC3T3-E1 cells in vitro, which seems linked to upregulation of 
TGF-β expression. Moreover, greater GPTMS surface concentrations induced greater 
secretion of TNF-α and IL-10 on RAW 264.7 macrophages. When implanted into rabbit 
tibia, osseointegration decreased with higher GPTMS concentrations. Interestingly, 
higher deposition of complement-related proteins C-reactive protein (CRP) and ficolin-2 
(FCN2), two main activators of distinct complement pathways, was observed. Taking all 
together, inflammatory potential increase seems to be GPTMS concentration-
dependent. Our results show that a greater adsorption of complement proteins can 
condition macrophage polarization. 
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1. Introduction 
Bone healing and recovery after orthopaedic, spinal, and dental surgical procedures are 
the prime concerns for surgeons and patients. Researchers are still seeking for 
improvements in clinical performance to assure complete post-trauma bone healing in 
the shortest possible time. The need to find these improvements drives the development 
of biomaterials with bioactive properties, capable of stimulating bone growth and 
biodegradation [1]. 
Hybrid silica sol-gel materials belonging to the second generation of bioglasses have 
unique physicochemical properties that make them ideal candidates for bone 
biomaterials [2]. By applying sol-gel as a coating to implants, the desired bioactive 
properties are obtained; additionally, these coatings are biocompatible, biodegradable, 
and able to release silica compounds in Si(OH)4 form. Silica is involved in bone 
metabolism, and enhances and promotes tissue mineralisation [3]. As such, the release 
of Si(OH)4 confers silica hybrid sol-gels their osteoinductive properties [4]. The 
application of sol-gels as coatings, in particular on titanium implants, is increasingly used 
in the field of dental implantology [5,6]. Moreover, the versatility of the sol-gel techniques 
enables the preparation of coatings with control over their degradation kinetics, which 
renders these materials attractive release vehicles. 
(3-Glycidoxypropyl) trimethoxysilane (GPTMS) is an organically modified alkoxysilane 
used as a precursor in the synthesis of sol-gel materials. It is non-cytotoxic, and the 
epoxy ring in its structure allows to functionalise the biomaterial network and modify its 
physicochemical properties [7]. Furthermore, the epoxy ring facilitates the incorporation 
of osteogenic or antibacterial drugs into the sol-gel network by covalent bonding [1]. 
Consequently, GPTMS-coated implants can be bioactivated with the desired signals to 
enhance biological performance. Nevertheless, despite the promising in vitro results [5], 
some sol-gels developed using GPTMS as a precursor demonstrated in vivo 
biocompatibility issues [8,9]. 
One of the main reasons for this discrepancy might be the lack of correlation between 
methods used for in vitro and in vivo evaluation of biomaterials [10]. Thus, further 
research into protein adhesion onto biomaterial surfaces becomes even more important 
for the development of improved formulations. The adhered proteins, depending on their 
type, conformation and quantity, might be responsible for cellular activation cascades 
and the subsequent cell behaviour, defining both in vitro and in vivo outcomes [11]. 
Biomaterials interact with their surroundings at several levels of biological organisation 
from the moment they are implanted, and come into contact with bodily fluids, such as 
blood. The protein–implant interface triggers the activation of coagulation cascades, 
immune cell migration and complement system pathways. Together, this initiates the 
natural inflammation processes in response to a foreign body [12] as well as the bone 
regenerative processes after implantation. The first proteins adsorbing onto the surface 
can vary in type, number, and conformation (caused by competitive displacement; 
Vroman effect), depending on protein–protein and protein–surface interactions [13]. 
An activation of immune cells by these proteins is required for appropriate bone healing. 
The surface-adsorbed proteins participate in processes including clot formation, tissue 
granulation and cell recruitment, in a coordinated manner, with direct cross-talk between 
the osteogenic and immune cells [14].The interplay between immunology systems and 
bone forming cells is critical for osseointegration and to understand microenvironmental 
and cellular cues [15]. Specifically the role of macrophages has recently been recognized 
as critical for bone homeostasis, directly affecting the cross-talk between osteoblasts 
and osteoclasts [16,17]. 
These plastic cells, in response to extracellular signals and/or interaction with proteins, 
can adopt two main sub-phenotypes: pro-inflammatory M1 and anti-inflammatory M2 
[18]. Emerging evidence indicates that the predominance of the M1 phenotype after 
implantation leads to chronic inflammation, compromising bone regeneration [19]. This 
can be related to the type and conformation of proteins attached to the material surface 
immediately after implantation. On the other hand, the M2 macrophage phenotype, 
known as a “reparative” phenotype, is described to have a pro-angiogenic character on 
tissue growth and development by secreting anti-inflammatory cytokines and 
osteoinductive molecules. M2a and M2c subsets, in particular, are suggested to have 
key roles in angiogenesis and vessel growth, enhancing endothelial cell sprouting and 
anastomosis through the secretion of PDGF-BB (M2a) and MMP9 (M2c) [20]. 
We here aimed to characterise complement protein adsorption to three sol-gel coatings 
made using different concentrations of GPTMS (0%, 35%, and 100%). Further, we 
analysed in vitro response to these materials using mouse osteoblastic cells MC3T3-E1 
and mouse RAW264.7 macrophages. Finally, the in vivo effects of these compositions 
and correlations between the in vivo and in vitro results were examined. 
2. Materials and Methods 
2.1. Substrate 
Ti discs (12 mm in diameter, 1-mm thick) were made from a bar of commercially 
available, pure, grade-4 Ti (Ilerimplant-GMI S.L., Lleida, Spain) and submitted to 
sandblasting, acid-etching treatment (SAE). The discs were abraded with 4-μm 
aluminium oxide particles and acid-etched by submersion in sulfuric acid for 1 h. They 
were then washed with acetone, ethanol and 18.2-Ω puriﬁed water (20 min in each liquid) 
in an ultrasonic bath and dried under vacuum. Finally, all Ti discs were sterilised using 
UV radiation. 
 
2.2. Sol-gel synthesis and sample preparation 
To obtain the hybrid silica coatings, the sol-gel method was used. The synthesis was 
performed using alkoxysilanes methyltrimethoxysilane (MTMOS), 3-glycidoxypropyl-
trimethoxysilane (GPTMS) and tetraethyl orthosilicate (TEOS), purchased from Sigma-
Aldrich (St. Louis, MO, USA). These precursors were combined in three distinct molar 
proportions to obtain the different compounds: 70 % MTMOS: 30 % TEOS (70M30T), 35 
% MTMOS: 35 % GPTMS: 30 % TEOS (35M35G30T) and 100 % GPTMS (100G). 2-
propanol (Sigma-Aldrich, St. Louis, MO, USA) was used as a solvent at a volume ratio 
(alcohol to siloxane) of 1:1. Hydrolysis of alkoxysilanes was carried out by adding (at a 
rate of a drop per second) the corresponding stoichiometric amount of acidified aqueous 
solution 0.1 M HNO3 (Panreac, Barcelona, Spain). The solution was stirred for 1 h and 
then left to rest for 1 h. The samples were prepared immediately afterwards. SAE-Ti 
discs were used as a substrate. The coating was performed employing a dip coater (KSV 
instrument-KSV DC). Discs were immersed in a sol-gel solution at a speed of 60 cm min-
1, left for 1 min, and removed at a 100 cm min-1. Finally, 70M30T and 35M30G30T 
samples were cured for 2 h at 80 °C, and 100G samples, for 2 h at 140 °C. 
 
2.3. Physicochemical characterisation of coated titanium discs 
The coatings were examined using scanning electron microscopy (SEM), employing the 
Leica-Zeiss LEO equipment under vacuum (Leica, Wetzlar, Germany). Platinum 
sputtering was utilised to make the materials more conductive. The material roughness 
was analysed using a mechanical profilometer Dektack 6M (Veeco Instruments, 
Plainview, NY, USA). Two coated discs of each composition were tested. Three 
measurements were performed for each disc to obtain the average values of the Ra 
parameter. The contact angle was measured using an automatic contact angle meter 
OCA 20 (DataPhysics Instruments, Filderstadt, Germany). Aliquots of 10 µL of ultrapure 
water were deposited on the disc surfaces at a dosing rate of 27.5 μL s-1 at 25 °C. Contact 
angles were determined using the SCA 20 software. Six discs of each material were 
studied, after depositing two drops on each disc. 
 
2.4. In vitro assays 
2.4.1. Cell culture 
 MC3T3-E1 (mouse calvaria osteosarcoma cell line) and RAW 264.7 (mouse murine 
macrophage cell line) were cultured on the coated titanium discs at a concentration of 1 
× 104 cells well-1, in 24-well culture plates (Thermo Fisher Scientific, Waltham, MA, USA). 
The culture medium for both cell lines contained DMEM with phenol red (Gibco-Life 
Technologies, Grand Island, NY, USA), 1 % of 100× penicillin/streptomycin (Biowest Inc., 
Riverside, KS, USA) and 10 % of fetal bovine serum (FBS) (Gibco-Life Technologies). 
After incubation for 24 hours at 37 °C in a humidified (95 %) atmosphere with 5 % CO2, 
the MC3T3-E1 cell-line medium was replaced with an osteogenic medium composed of 
DMEM with phenol red 1×, 1 % penicillin/streptomycin, 10 % FBS, 1 % ascorbic acid (5 
mg mL-1) and 0.21 % β-glycerol phosphate and incubated again under the same 
conditions. The culture medium was changed every 48 hours. In parallel, MC3T3-E1 
cells were allowed to differentiate for 7 and 14 days for RNA isolation. 
The medium from RAW 264.7 cell culture on the titanium discs was harvested at 24 and 
72 h to measure IL1-β, TNF-α, IL-10 and TGF-β content using ELISA, and the cells were 
fixed for immunostaining. In parallel, cells at the same concentration (1 × 104 cells) 
incubated without biomaterials were used as a control of culture conditions. 
 
2.4.2. Cytotoxicity 
Materials were incubated with cell medium for 24 h. The biomaterial cytotoxicity was 
evaluated after 24 h of contact of MC3T3-E1 cells with the medium extracted after the 
initial incubation, using spectrophotometry. The CellTitter 96 Proliferation Assay 
(Promega®, Madison, WI, USA) was employed to measure cell viability after 24-h 
incubation, following manusfacturer’s instructions. The medium with no cells was used a 
negative control, and latex, known to be toxic to the cells, was used as a positive control. 
 
2.4.3. Alkaline phosphatase (ALP) activity 
The conversion of p-nitrophenylphosphate (p-NPP) to p-nitrophenol was used to assess 
ALP activity, as previously described [9]. The results were presented as mmol of 
p-nitrophenol/hour (mmol PNP h-1). The data were expressed as ALP activity normalised 
to the total protein content (µg µL-1) obtained using Pierce BCA assay kit (Thermo Fisher 
Scientific, Waltham, MA, USA) after 7 and 14 days of cell culture. 
 2.4.4. RNA isolation and cDNA synthesis 
Total RNA isolation and subsequent cDNA synthesis were adapted from the protocol 
described in [21]. Briefly, for each sample, approximately 1 µg of total RNA was 
converted to cDNA using PrimeScript RT Reagent Kit (Perfect Real Time) (TAKARA Bio 
Inc., Shiga, Japan). The resulting cDNA was diluted in DNase-free water to a 
concentration suitable for reliable RT-PCR analysis. 
 
2.4.5. Osteogenic expression 
The primers for assessing the expression levels of the markers ALP, IL-6, COL I and 
TGF-β were designed using specific DNA sequences for these genes available from 
NCBI (https://www.ncbi.nlm.nih.gov/nuccore), employing the PRIMER3plus software 
tool (http://www.bioinformatics.nl/cgi-bin/primer3plus/primer3plus.cgi). The expression 
levels, shown in Table 1, were measured using primers purchased from Life 
Technologies S.A. (Gaithersburg, MD). 
 
Table 1: Primers used for qRT-PCR 
Gene Forward sense Reversed sense 
IL-6 AGTTGCCTTCTTGGGACTGA TCCACGATTTCCCAGAGAAC 
COLI CCTGGTAAAGATGGTGCC CACCAGGTTCACCTTTCGCACC 
TGF-β TTGCTTCAGCTCCACAGAGA TGGTTGTAGAGGGCAAGGAC 
GADPH TGCCCCCATGTTTGTGATG TGGTGGTGCAGGATGCATT 
 
GADPH was used as a housekeeping gene to normalise the data obtained from the qRT-
PCR and calculate the relative fold-change between different conditions. qPCR 
reactions were carried out using SYBR Premix Ex Taq (Tli RNase H Plus) (TAKARA), in 
a StepOne Plus™ Real-Time PCR System (Applied Biosystems, Foster City, California, 
USA). The cycling parameters were as follows: an initial denaturation step at 95 °C for 
30 s; followed by 95 °C for 5 s and 60 °C for 34 s for 40 cycles. The final melt-curve 
stage comprised a cycle of 95 °C for 15 s and 60 °C for 60 s. 
 
2.4.6. Immunocytochemistry double staining 
RAW 264.7 cultures were fixed in 4 % paraformaldehyde for 10 min (Sigma-Aldrich, St. 
Louis, MO, USA) and washed 5 times in 1x PBS. The samples were blocked in 1x PBS 
containing 0.5 % BSA (Sigma-Aldrich, St. Louis, MO, USA) and 1 % Triton X-100 (Sigma-
Aldrich, St. Louis, MO, USA). They were incubated with donkey anti-mouse CD206 
primary antibody (Abcam, Cambridge, UK) diluted 1:250 in PBS containing 0.5 % BSA 
and 0.5 % Tween-20 (Sigma-Aldrich), overnight at 4 °C. The discs were then washed 5 
times in 1x PBS and incubated with a mixture of secondary antibodies composed of Goat 
anti-Donkey Biotin (Jackson ImmunoResearch Europe, Ltd., Cambridgeshire, UK) 1:500 
and Streptavidin Alexa Fluor 647 1:500 (Thermo Fisher Scientific, US) for 1 h at room 
temperature. Cells were washed 5 times again with 1x PBS with 0.5 % Triton X-100 and 
incubated with the primary antibody IL7-R (Santa Cruz Biotechnology, Dallas, TX, USA) 
at 4 °C overnight. After 5 more washes with 1x PBS with 0.5 % Triton X-100, the discs 
were incubated with the secondary antibody Goat anti-Rabbit Alexa Fluor 488 (Thermo 
Fisher Scientific, Waltham, MA, USA) for 1 h at room temperature. After the next 5 
washes with 1x PBS with 0.5 % Triton X-100, the discs were incubated with DAPI 
(Roche, Basel, Switzerland) for another hour to stain the cell nuclei. 
The discs were then removed from the wells, mounted on coverslipped slides with 
mounting medium (4.8 % poly(vinyl alcohol-co-vinyl acetate); 12 % glycerol; 0.2M Tris-
HCl; 0.02 % sodium azide) and stored at 4 °C for the fluorescence microscopy analysis. 
All images were captured using the same exposure time. 
 
2.4.7. Cytokine quantification 
The ELISA kits for TNF-α, IL1-β, IL-10 and TGF-β (Thermo Fisher Scientific, Waltham, 
MA, USA) were employed to quantify the proteins produced by RAW 264.7 cells cultured 
on each of the materials tested (following manufacturer’s instructions). 
 
2.5. Proteomic analysis 
Proteomic analysis was performed as described previously [22], with minor variations. 
Briefly, the eluted protein was in-solution digested, following the FASP protocol 
established by Wisnewski et al. [23] and loaded onto a nanoACQUITY UPLC System 
connected online to an SYNAPT G2-Si MS System (Waters, Milford, MA, USA). Each 
material was analysed in quadruplicate. The statistical protein analysis was carried out 
using Progenesis software (Nonlinear Dynamics, Newcastle, UK). The functional 
annotation of the identified differential proteins was performed using the DAVID GO 
annotation programme (https://david.ncifc rf.gov/). Proteins were quantified based on the 
intensity of their three most abundant peptides, when available. Proteins with analysis of 
variance (ANOVA) p < 0.05 and a ratio higher than 1.3 in either direction were considered 
significantly different. Each material was analysed in quadruplicate. 
  
 2.6. In vivo experimentation 
The in vivo experimentation was performed as described in [22]. Briefly, the in vivo 
procedures and histological evaluation of the three tested materials, 70M30T, 
35M35G30T and 100G, were carried out using the tibia of New Zealand rabbits 
(Oryctolagus cuniculus) as the experimental model. All the experiments were conducted 
in accordance with the protocols of the Ethical Committee of the Valencia Polytechnic 
University (Spain), the European guidelines and legal conditions described in R. D. 
223/1988 of March 14th and the Order of October 13th, 1988, of the Spanish 
Government on the protection of animals used for experimentation and other scientific 
purposes. The dental implants, supplied by Ilerimplant S.L. (Lleida, Spain), were the 
Frontier model (3.75-mm diameter and 8-mm length) with SAE surface treatment. Four 
implants per animal were used, two control non-coated titanium implants on one tibia 
and two coated implants (of each material) on the other. The implantation period was 2 
weeks. The samples for histological examination were embedded in methyl methacrylate 
using EXAKT technique (EXAKT Technologies, Inc., Oklahoma, USA). The slides were 
stained with Stevenel’s blue and van Gieson’s picro-fuchsin, following the procedure 
described by Maniatopoulos et al. [24]. Digital images of the tissues were recorded using 
a brightfield Leica DM4000 B microscope and a DFC420 digital camera. 
 
2.7. Statistical analysis	
Data were analysed using a one-way ANOVA combined with a Newman-Keuls multiple 
comparison post-hoc test where appropriate (GraphPad Prism; GraphPad Software, 
Inc., California, USA). P-values ≤ 0.05 were considered statistically significant. 
  
3. Results 
3.1. Synthesis and physicochemical characterisation 
The different sol-gels were synthesised and applied as coatings on titanium surfaces. 
They were homogeneous and adhered well to the Ti discs. Different topographies were 
observed via SEM micrographs, showing coverage of the original SAE-Ti irregular 
surface (Fig. 1a-c). The morphological differences were concordant with the measured 
surface roughness (Ra values; Fig. 1d): surface roughness significantly decreased with 
increasing GPTMS precursor content in the sol-gel coating. 
 
 
Figure 1. SEM micrographs of 70M30T (a), 35M35G30T (b) and 100G (c) sol-gel coated 
surfaces. Calibration bar, 10 µm. (d) Ra values for each formulation (n = 6) and (e) 
Wettability of substrates by water contact angle (WCA) measurements (n=6). Statistical 
analysis was performed using one-way ANOVA with Newman-Keuls post-hoc test. *, P 
< 0.05; **, P < 0.01; ***, P < 0.001. 
 
The measured contact angles were 50.78 ± 1.82°, 50.39 ± 3.78° and 56.51 ± 1.69° for 
70M30T, 35M35G30T and 100G coatings, respectively. 
 
3.2.  In vitro experimentation 
The 70M30T and 35M35G30T sol-gel coatings used in this study enhanced the cellular 
viability for osteoblastic MC3T3-E1 cells (Fig. 2a) when compared to positive controls. 
The osteogenic differentiation potential, assessed by measuring ALP activity, showed no 
apparent differences between the distinct sol-gel materials (Fig. 2b; p≥0.05). 
  
 
Figure 2. MC3T3-E1 in vitro assays. a) MC3T3-E1 cell survival assay. Cells in a well 
without a disc were used as a positive control, 100% cell viability – the dashed line 
represents the limit above which the material is considered cytotoxic. b) ALP activity (mM 
PNP h−1) normalised to the total protein levels (μg μL−1) in the MC3T3-E1 cells cultivated 
on titanium discs with the different formulations. Statistical analysis was performed using 
one-way ANOVA with Newman-Keuls post-hoc test. *, P < 0.05; **, P < 0.01. 
 
TGF-β expression was significantly upregulated in the MCT3T3-E1 cells cultured on the 
sol-gel hybrid surfaces (in comparison with the SAE-Ti). Interestingly, the upregulation 
of this gene was found for the materials containing GPTMS (100G at 7 days and 
35M35G30T at 14 days; Fig. 3). 
 
Figure 3.  Gene expression of osteogenic markers a) IL6, b) TGF-β and c) COL-1 in 
MC3T3-E1 osteoblastic cells cultured on different formulations. Relative mRNA 
expression was determined by RT-PCR after 7 and 14 days of culture. Statistical analysis 
was performed using one-way ANOVA with Newman-Keuls post-hoc test. *, P < 0.05; **, 
P < 0.01; ***, P < 0.001. 
 
To evaluate the effect of different coatings on RAW264.7 macrophage polarization, pro- 
and anti-inflammatory cytokine secretion profiles were determined. The cytokine 
secretion profiles at 24h of culture were similar among coatings. After 72h, a significantly 
increased release of TNF-α (Fig. 4c; p-value < 0.001) and IL-10 (Fig. 4d; p-value < 0.001) 
was observed for macrophages cultured on the material with the highest concentration 
of GPTMS (100G). On the two coatings with lower concentrations of this precursor, the 
values of TNF-α release did not differ (Fig. 4c; p>0.05). 
 
 
 
Figure 4. Cytokine expression. IL1-β (a), TGF-β (b), TNF-α (c) and IL10 (d) in RAW 
264.7 macrophages at 24- and 72-h time points. Statistical analysis was performed using 
one-way ANOVA with Newman-Keuls post-hoc test. *, P < 0.05; **, P < 0.01; ***, P < 
0.001. 
 
M1 macrophage marker IL7-R showed increased fluorescent expression for macrophage 
cultures on the GPTMS materials at the 72-h time point compared to the material with 
no GPTMS (Fig. 5a′-c′; p-value < 0.001).No significant differences were found for CD206 
fluorscent expression between materials. (Fig. 5a’’-c’’; p-value ≥ 0.05). 
  
 
Figure 5. Immunostaining of macrophages cultured on the 70M30T, 35M35G30T and 
100G sol-gel hybrid coatings, after 72 h. IL7-R (a′-c′) was used as a pro-inflammatory 
M1 marker and CD206 (a′′-c′′), the anti-inflammatory M2 marker. The relative corrected 
total cell fluorescence (CTCF) of these markers (d and e) was quantified using ImageJ. 
Statistical analysis was performed by one-way ANOVA with Newman-Keuls post-hoc 
test, *** P< 0.001. 
 
3.3. In vivo experimentation 
Fig. 6 displays the histological results for the coatings employed. Three notable features 
were observed. The implant grooves on the cortical region into which the bone tissue 
penetrates were similar for 35M35G30T and 70M30T. This was less pronounced for the 
100G sample. The spicules from the cortical, following the implant surface in the 
medullary cavity, were longer greater and more developed on 70M30T than on the other 
two formulations (approximately a half of the length on 35M35G30T and one-third on 
100G). 
The mean size of the multinucleated giant cells (contacting the implant or coating 
surface) on the medullary zone was smaller on the 70M30T samples (approximately 0.25 
mm) in comparison with the other two materials (approximately 0.3 mm). Moreover, the 
density of giant cells covering the outline of titanium implant and coating (number of cells 
per length) was also lower on the 70M30T material (0.7 cells per mm) than on the other 
two formulations (1.3 cells per mm for 35M35G30T and 1 cell per mm for 100G). 
 
Figure 6. Microphotographs of titanium implants. Panoramic images of (a) 70M30T, (b) 
35M35G30T and (c) 100G implants showing the cortical bone region and the medullary 
cavity. The implant grooves in (b) delimit the metal layer of the implant detached during 
the processing of the sample. 
 
3.4. Proteomic analysis 
The eluted proteins analysed using LC-MS/MS and Progenesis QI software and 
subsequent DAVID analysis show some significant differences between the types and 
functions of the proteins adsorbed to the different materials tested. One hundred 
seventy-six proteins are identified as adsorbed commonly to the three formulations. 
Among this group, and after Progenesis comparative analysis, sixteen proteins are found 
to be directly associated with immune response processes, i.e. the complement system. 
These are significantly more adsorbed onto the materials made with GPTMS, with a 
tendency for an increased abundance on materials with more GPTMS (Supplementary 
table). 
A significantly higher adsorption of FCN2 to the 100G material was seen in comparison 
with the other two materials (70-fold increase in comparison with the 70M30T and 8.5-
fold increase in comparison with the 35M35G30T). CRP and FCN2 showed a tendency 
for increased attachment to the formulation with the highest concentration of GPTMS. 
The normalized abundance of proteins CRP, FCN2, CO3, CO5, C1q, that play a central 
role on complement system pathway development is stated on Fig. 7. It is clear the 
greater adsorption of these onto the highest GPTMS content formulation. 
At the same time, DAVID identifies SAMP as the protein prevalently associated with the 
materials with high GPTMS content. This pentraxin-family protein, sharing some traits 
with the CRP, is also involved in the processes of immune and acute inflammatory 
responses [25]. However, its effect on complement activation cascades is less clear than 
that of the CRP. The increase in the levels of VTNC and APOE on the GPTMS-coated 
materials is also worth mentioning (Supplementary table). 
 
 
Figure 7. Normalized abundance of complement-related main proteins adsorbed to 
70M30T, 35M35G30T and 100G. Statistical analysis was performed using one-way 
ANOVA with Newman-Keuls post-hoc test. * show significance when compared to the 
70M30T coating.  ANOVA, P<0.05. 
  
4. Discussion 
The urgent clinical need for orthopaedic biomaterial-based treatments is shifting the 
research in this field towards the design of so-called “bioactive” materials capable of 
interaction and integration in the biological microenvironment (e.g. molecules, cells) [26]. 
This interaction should be ideally modulated and guided through the evolution of 
materials with both osteoconductive and osteoinductive properties, leading ultimately to 
improved osseointegration [21]. As found in our previous studies, some of the here tested 
materials possess such intrinsic properties. However, certain processes, particularly 
those related to the material-induced immune response, can hamper the successful 
application of biomaterials in complex biological contexts [8,9]. First step in the design of 
new biomaterials with specific properties is to perform in vitro experimentation but the 
limitations of classical in vitro testing are widely recognised. However, the lack of 
correlation with the in vivo results has been largely disregarded [10].  Thus, there is a 
clear need to explore alternative assessment methodologies for biomaterial-based 
testing. 
The use of hybrid silica sol-gel materials applied as coatings for dental implantation has 
been attracting increasing interest due to the intrinsic osteogenic properties of these 
formulations. This osteogenic potential depends on the degradation properties, i.e. the 
release of silica compounds in the Si(OH)4 form, which can boost the osteoblastic 
behaviour in areas close to the coating [5]. 3-glycidoxypropyl-trimethoxysilane (GPTMS) 
is one of the organo-modified alkoxysilanes commonly employed in the development of 
hybrid materials [27] and is increasingly used in bone tissue engineering [28]. GPTMS 
has a characteristic epoxy ring susceptible to nucleophilic attack. 
Here, we focused on the characterisation of the protein layer adsorbed onto materials 
with different concentrations of GPTMS and examined the correlations with in vitro and 
in vivo outcomes. We evaluated the osteogenic properties of this compound and 
examined the inflammatory effect of increasing concentrations of GPTMS; such 
increased GPTMS content might impair the biocompatibility of the coatings. The different 
chemical composition of the three formulations used in our experiments entails varying 
degrees of functionalisation of the surfaces. It was observed some clear morphological 
differences between the tested materials (Fig. 1), in which these distinct chemical 
compositions have proven to ultimately and naturally affect protein deposition on their 
surfaces.  
In vivo, the 100G coating did not increase the osteogenic activity. Adding GPTMS to 
coating materials did not improve osteogenesis in those experiments. In fact, the bone 
spicules around these implants were shorter. However, the mean size and cell density 
of the multinucleated giant cells in contact with the coated implant were higher for both 
GPTMS-coated samples; this might be associated with a strengthened immune 
response of the host. The formation of these cells requires an initial adhesion and is 
affected by the type of surface and the adsorbed blood proteins [29]. The appearance of 
foreign-body giant cells can inhibit the bone formation process and impair the material 
biocompatibility [30]. 
For the 100G material, our proteomic study showed an increase in the affinity of proteins 
with a direct role in the complement pathway processes, in comparison with the other 
two formulations. The significantly improved adsorption of FCN2 and CRP, identified by 
DAVID as main activators of distinct complement system pathways [31,32] (lectin and 
classical, respectively), shows that this formulation strengthens the inflammatory 
response. The rise in the affinity of complement proteins (CO3, CO5, C1QA, C1QB, 
CO7, C1R, C1S, CO8B and CO6) and the formation of C5b-9 membrane attack complex 
can be related to the increased deposition of these two activators. Within this cluster, 
CO3, CO5, CO6 and CO8G are common to the three pathways, participating in the 
termination step forming the C5b-9 membrane attack complex [33]. CO3 modulates the 
complement cascade activation and is a biomarker of inflammatory response to 
biomaterials [34]. CFAD is exclusive to the alternative pathway of the complement 
system; it is crucial for the cleavage of the lysine-arginine bond in the complement factor 
B [35,36]. Many of the complement proteins are activated in the host at the site of 
inflammation, forming convertases (namely C3 and C5 convertases) as the end-product. 
This results in the successive cleaving of the components, in a gain-and-loss manner, in 
an attempt to fight the pathogen or foreign body [33]. However, the increased abundance 
of proteins like VTNC and APOE might also result in a rise in the osteogenic potential. A 
study performed by our group has highlighted the bioactive potential of this type of 
coatings, associated with these two proteins [37]. However, at the time of increased cell 
inflammatory response, it is difficult to identify the specific role of these proteins in the 
regenerative processes. 
ELISA analysis showed an increased secretion of TNF-α and IL-10 when the formulation 
100G is used for macrophage culture. This data agrees with the results of the double 
staining, in which is observable an increased predominance of M1 macrophages on the 
coatings with GPTMS, showing a possible inflammatory potential for these coatings. 
 TNF-α release is typically associated with macrophage differentiation into the pro-
inflammatory phenotype (M1). Interestingly, it has been reported that human CRP 
administered to rats induces macrophage polarisation to M1 and is associated with an 
increase in TNF-α release [38]. The release of IL-10, even though it is considered a M2 
marker for human cells, is oppositely regulated on mice cells [39], and it is significantly 
increased on the 100G material. This might be due to the presence of the epoxy ring; 
the macrophages might mistake it for lipopolysaccharide (LPS), as LPS also contains 
epoxy rings. It has been reported that the LPS increases the release of IL-10  on mouse 
cells [40,41]. Hence, we might be tempted to infer that the GPTMS causes macrophage 
differentiation into a pro-inflammatory M1 state not only via the TNF-α release but also 
by increasing the levels of IL-10. Although the M1 macrophages are necessary for the 
early inflammatory processes and wound healing, the increased secretion of TNF-α by 
these macrophages can impair bone formation. This cytokine is a potent factor of 
osteoclastogenesis and, at the same time, an inhibitor of osteoblastogenesis [42]. Wu et 
al. have reported that the predominance of the M1 phenotype on bone tissue may 
enhance the osteonecrosis through the liberation of TNF-α [43]. Hence, continuing high 
abundance of M1 macrophages might be associated with the worst in vivo outcome. 
However, it is tempting to hypothesise that increased and immediate deposition of 
complement proteins on a surface affects the macrophage behaviour, to boost 
phagocytosis of the pathogens or foreign bodies [44,45]. The macrophage activation 
results in binding various complement proteins (C1q, MBL and even ficolins) to 
complement receptors on these cells. This modulates the cytokine production, the 
magnitude of the consequent immune response and pathogen opsonisation [46]. 
Complement proteins like anaphylatoxins C3a, C5a and the membrane attack complex 
C5b-9 are associated with macrophage induction into the inflammatory M1 phenotype 
[47,48]. The strength of immune response on the tested materials is also shown by the 
immunostaining, demonstrating discernible intensity differences for the M1 marker IL7-
R. On the 100G formulation, the intensity of this marker was higher than on the other two 
materials. 
The improved osteogenicity of GPTMS formulations, due to an increase in the 
abundance of vitronectin and APOE and a rise of osteogenic gene expression in vitro, is 
not clearly confirmed by the histological results. A possible reason for this disparity might 
be the significant immune response detected on this coating. The proteomic analysis 
shows that the proteins related to complement cascade activation are predominantly 
attached to this type of coating, and an increase in the macrophage-activated immune 
response is observed. 
  
5. Conclusions 
The increased adsorption of specific complement proteins and likely predominance of 
pro-inflammatory macrophage polarization here is related to the inferior in vivo 
performance of biomaterial surfaces containing different concentrations of GPTMS 
precursor. These data hence suggest an important role for complement proteins in 
determining the immune response to biomaterials. 
Different complement pathways seem to be gradually activated in response to the 
increasing amounts of GPTMS, since an increased adsorption of FCN (lectin pathway 
activator) was observed on a GPTMS dose-dependent manner.  
The results of this study are in agreement with our previous studies, highlighting the 
potential of proteomic analysis as an important tool for predicting in vivo outcomes. 
Moreover, the analysis of macrophage polarisation patterns on biomaterials might 
become a useful approach to correlation of in vitro assessment with in vivo outcome. 
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